Site Archives psychiatry
Three Harvard University doctors have been caught in a failure to report over $3 million in income that they receive from drug companies. One of the men was very involved in research that has lead to a huge boom for drug companies in dishing out antipsychotic drugs to children. The information was entered into the [...]
Autism is characterized by profound disturbance in the emergence of social relations, apparent as early as the first months of life and almost always by age three years (1). Disturbances in brain maturation appear to be a cause of this syndrome, which may be exacerbated by deficiencies in certain nutrients (e.g., vitamin B6, magnesium, [...]
What many people have been suspecting all along with regards to the accurate reporting of drug testing was brought to light in the January issue of the New England Journal of Medicine. Drug companies have been engaging in selective reporting of antidepressant drug trials and, by doing so, have been exaggerating the effectiveness of these [...]
Columbia University “Expert” Panel too Biased to Impartially Review Suicidal Effects of Antidepressant Drugs
Children’s Lives Will Continue To Be At Risk Due To Conflicts Of Interest
Amid increasing controversy surrounding the suicidal effects of numerous Selective Serotonin Reputake Inhibitor (SSRI) antidepressants being prescribed to children and adolescents, the U.S. Food and Drug Administration (FDA) referred clinical trial studies on SSRIs to Columbia University, for a “distinguished panel” of “experts” [...]
Now a Stanford study described in the May 24-25, 2008 the Wall Street Journal by reporter Jonathan Kaufman has shown that nearly one in ten of 11th graders take stimulants like Ritalin, Adderall and Concerta without a prescription. Nine percent are taking stimulants illegally.
Read the rest of this article by Dr. Peter Breggin at The [...]
Over the past 50 years, there has been an astonishing increase in severe mental illness in the United States. The percentage of Americans disabled by mental illness has increased fivefold since 1955, when Thorazine-remembered today as psychiatry’s first “wonder” drug-was introduced into the market. The number of Americans disabled by mental illness has nearly doubled [...]
The Food and Drug Administration (FDA) has asked makers of all antidepressant medications to update existing labels to include warnings about increased risks of suicidal thinking and behavior, known as suicidality,in young adults ages 18 to 24 during initial treatment (generally the first one to two months).
The proposed labeling update follows similar labeling changes made [...]
The U.S. Food and Drug Administration (FDA) has directed the manufacturers of all drug products approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) to develop Patient Medication Guides to alert patients that possible cardiovascular risks and adverse mental symptoms are associated with the medicines. The Guides are intended to advise them of precautions [...]
Find It Quickly
Find what you're looking for quickly by using our keyword search. Can't find it? Try our links below.